Cognizance Market Research

Global Biologics Market to Reach US$985.61 Billion by 2032, Driven by Chronic Disease Rise and Biotech Innovations at 8.37% CAGR

Biologics are the biological drug product that is produced from living organism or contain components of living organisms. Biologic drugs include a wide variety of …

Read More

Biologics Contract Manufacturing Market

Global Biologics Contract Manufacturing Market to Reach US$29.03 Billion by 2030, Driven by Rising Chronic Diseases and Outsourcing Trends

The market of biologics encompasses pharmaceuticals derived from living cells or organisms, including proteins, antibodies, and gene therapies. In contrast to conventional medications created through …

Read More

Electroporation Instruments

Global Electroporation Instruments Market to Reach US$288.9 Million by 2030, Driven by Rise in Chronic Diseases and Biotech R&D

The biotechnology, pharmaceutical, and contract research industries all primarily use electroporation technologies. It is applied in microbiology to modify prokaryotic cells by introducing artificial DNA …

Read More

Monoclonal Antibody Therapeutics Market

Global Monoclonal Antibody Therapeutics Market to Reach US$501.5 Billion by 2030, Driven by Rising Chronic Diseases and R&D Investment

Monoclonal antibodies, commonly known as moAbs or mAbs, are lab-made proteins that function in human bodies similarly to antibodies. Your immune system includes antibodies as …

Read More